RNA modification in mRNA cancer vaccines

56Citations
Citations of this article
66Readers
Mendeley users who have this article in their library.

Abstract

RNA modification is manifested as chemically altered nucleotides, widely exists in diverse natural RNAs, and is closely related to RNA structure and function. Currently, mRNA-based vaccines have received great attention and rapid development as novel and mighty fighters against various diseases including cancer. The achievement of RNA vaccines in clinical application is largely attributed to some methodological innovations including the incorporation of modified nucleotides into the synthetic RNA. The selection of optimal RNA modifications aimed at reducing the instability and immunogenicity of RNA molecules is a very critical task to improve the efficacy and safety of mRNA vaccines. This review summarizes the functions of RNA modifications and their application in mRNA vaccines, highlights recent advances of mRNA vaccines in cancer immunotherapy, and provides perspectives for future development of mRNA vaccines in the context of personalized tumor therapy.

Cite

CITATION STYLE

APA

Mei, Y., & Wang, X. (2023, October 1). RNA modification in mRNA cancer vaccines. Clinical and Experimental Medicine. Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/s10238-023-01020-5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free